X T L Biopharmaceuticals reported $761K in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
X T L Biopharmaceuticals USD 761K 1.45M Jun/2025